An emerging immunotherapy technique uses patients' own T-cells to develop a personalized, targeted anticancer treatment. This review discusses the CAR T-cell process, and the nurses' role in recognizing and managing its toxicities.

Radical improvements in diagnostic services, cancer education, and training, and policies that encourage integration between primary and specialist care, primary care doctors could hold the key to meeting the growing demand for cancer care.